Cumberland Pharmaceuticals (CPIX)
8.49
+0.01 (0.12%)
Upcoming Events
Latest Headlines
Form 8-K CUMBERLAND PHARMACEUTICA For: Oct 23
October 23, 2026 5:02 PM - SEC Filing
Cumberland Pharmaceuticals reports Phase 2a ifetroban trial results
October 23, 2026 4:06 PM - StreetInsider
Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results
October 23, 2026 4:05 PM - PR NewsWire
CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL
October 23, 2026 9:05 AM - PR NewsWire
CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
October 19, 2026 4:06 PM - PR NewsWire
Form 8-K/A CUMBERLAND PHARMACEUTICA For: Apr 21
September 11, 2026 4:52 PM - SEC Filing
Form 8-K CUMBERLAND PHARMACEUTICA For: Aug 28
August 28, 2026 5:09 PM - SEC Filing
Form 10-Q CUMBERLAND PHARMACEUTICA For: Jun 30
August 7, 2026 5:12 PM - SEC Filing
Cumberland Pharmaceuticals (CPIX) Reports Q2 Loss of $0.20
August 4, 2026 5:57 PM - StreetInsider
Form 8-K CUMBERLAND PHARMACEUTICA For: Aug 04
August 4, 2026 5:21 PM - SEC Filing
CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
August 4, 2026 5:06 PM - PR NewsWire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
July 28, 2026 4:05 PM - PR NewsWire
Full Article List